Green Thumb Industries Inc. (GTBIF)
(Delayed Data from OTC)
$11.19 USD
+0.16 (1.45%)
Updated Aug 8, 2024 09:44 AM ET
2-Buy of 5 2
A Value A Growth A Momentum A VGM
Brokerage Reports
0 items in cart
Green Thumb Industries Inc. [GTBIF]
Reports for Purchase
Showing records 21 - 40 ( 132 total )
Company: Green Thumb Industries Inc.
Industry: Medical - Products
Weekly ReHash: Capital Remains Tight but Will Flow with Federal Reform Changes
Provider: Roth Capital Partners, Inc.
Analyst: FORTUNE S
Company: Green Thumb Industries Inc.
Industry: Medical - Products
Weekly ReHash: Cash Flow Key and Rescheduling Look
Provider: Roth Capital Partners, Inc.
Analyst: FORTUNE S
Company: Green Thumb Industries Inc.
Industry: Medical - Products
Weekly ReHash: Percolating Cannabis Technicals, Trading Volume, Valuations
Provider: Roth Capital Partners, Inc.
Analyst: FORTUNE S
Company: Green Thumb Industries Inc.
Industry: Medical - Products
Weekly ReHash: Pressure on DEA to Reschedule After HHS Findings
Provider: Roth Capital Partners, Inc.
Analyst: FORTUNE S
Company: Green Thumb Industries Inc.
Industry: Medical - Products
2024 Cannabis Industry Outlook: Resetting and Anticipating Regulatory Catalysts
Provider: Roth Capital Partners, Inc.
Analyst: FORTUNE S
Company: Green Thumb Industries Inc.
Industry: Medical - Products
Weekly ReHash: State Led Growth Story to Continue in 2024
Provider: Roth Capital Partners, Inc.
Analyst: FORTUNE S
Company: Green Thumb Industries Inc.
Industry: Medical - Products
Yearly ReHash: Biggest Developments in Cannabis in 2023
Provider: Roth Capital Partners, Inc.
Analyst: FORTUNE S
Company: Green Thumb Industries Inc.
Industry: Medical - Products
Weekly ReHash: New York Set to Expand Adult-use in 2024
Provider: Roth Capital Partners, Inc.
Analyst: Research Department
Company: Green Thumb Industries Inc.
Industry: Medical - Products
Company: Green Thumb Industries Inc.
Industry: Medical - Products
Company: Green Thumb Industries Inc.
Industry: Medical - Products
Company: Green Thumb Industries Inc.
Industry: Medical - Products
Q323 Results Beat Forecasts, More to Come in 2024 as Multiyear Capex Cycle with $600M Invested Begins to Bear Fruit
Provider: Echelon Welath Partners
Analyst: SEMPLE A
Company: Green Thumb Industries Inc.
Industry: Medical - Products
3Q23 Beat MD Driven, Best-In-Class CF Drives High Capex Investments
Provider: Roth Capital Partners, Inc.
Analyst: FORTUNE S
Company: Green Thumb Industries Inc.
Industry: Medical - Products
Cannabis Industry Update: Ohio Becomes 24th Adult-Use State
Provider: Roth Capital Partners, Inc.
Analyst: Research Department
Company: Green Thumb Industries Inc.
Industry: Medical - Products
Consumer - Weekly ReHash: 3Q23 Earnings Week I
Provider: Roth Capital Partners, Inc.
Analyst: FORTUNE S
Company: Green Thumb Industries Inc.
Industry: Medical - Products
Weekly ReHash: Declining Prices Drives Volume + Illicit Conversion
Provider: Roth Capital Partners, Inc.
Analyst: FORTUNE S
Company: Green Thumb Industries Inc.
Industry: Medical - Products
Cannabis Industry Update: 3Q23 Preview
Provider: Roth Capital Partners, Inc.
Analyst: Research Department
Company: Green Thumb Industries Inc.
Industry: Medical - Products
Weekly ReHash: MSO Benchmark Scoring Ahead of 3Q23 Earnings
Provider: Roth Capital Partners, Inc.
Analyst: FORTUNE S
Company: Green Thumb Industries Inc.
Industry: Medical - Products
Weekly ReHash: U.S. Cannabis Industry 3Q23 Insight
Provider: Roth Capital Partners, Inc.
Analyst: FORTUNE S
Company: Green Thumb Industries Inc.
Industry: Medical - Products
Weekly ReHash: U.S. Cannabis Remains a State Led Growth Story
Provider: Roth Capital Partners, Inc.
Analyst: FORTUNE S